Revenue: The sum of all revenue fields included for a company's operating activities.
Tango Therapeutics, Inc. (TNGX) had Revenue of $42.07M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$42.07M |
$-130.30M |
|
-- |
|
$42.07M |
|
$187.66M |
|
$-145.59M |
|
$15.50M |
|
$-130.09M |
|
$-130.09M |
|
$-130.30M |
|
$-130.30M |
|
$-130.30M |
|
$-130.30M |
|
$-145.59M |
|
$-147.71M |
|
109.23M |
|
109.23M |
|
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$266.34M |
|
$8.10M |
|
$50.15M |
|
$316.49M |
|
$38.17M |
|
-- |
|
$78.81M |
|
$116.97M |
|
$199.52M |
|
$199.52M |
|
$199.52M |
|
107.73M |
|
| Cash Flow Statement Financials | |
$-131.50M |
|
$86.13M |
|
$47.66M |
|
$69.81M |
|
$72.10M |
|
$2.29M |
|
$28.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-346.09% |
|
-346.09% |
|
-351.12% |
|
-309.24% |
|
-309.73% |
|
$-132.25M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
-- |
|
-- |
|
-65.31% |
|
-65.31% |
|
-41.17% |
|
-65.31% |
|
$1.85 |
|
$-1.21 |
|
$-1.20 |
|